Top 5 Upcoming IPO 2023 : Boat, Oyo, Snapdeal, Emcure Pharmaceuticals andMobikwik

Welcome to the Top 5 Upcoming IPO post by realstockcertificates.com. Here in this article, we will provide complete information about Top 5 Upcoming IPO  like  boAT, OYO, Snapdeal, Emcure Pharmaceuticals,  Mobikwik. This post draws on our years of market experience . Hope you will like this Top 5 Upcoming IPO  information, and please share this informational & valuable article with your friends.

S.NO. IPO NAME
1.

baAT IPO

2.

OYO IPO

3.

Snapdeal IPO

4.

MobiKwik IPO

5.

Emcure Pharmaceutical IPO

baAT IPO

Imagine Marketing Limited, the parent company of the Indian direct-to-consumer electronics firm Boat, has submitted a Draft Red Herring Prospectus (DRHP) to SEBI for an Initial Public Offering (IPO) valued at 2000 crore INR. Established in 2016, the company boasts backing from prominent investors such as Fireside Ventures, Qualcomm Ventures LLC, and South Lake Investments Ltd. The IPO comprises a fresh issue of 900 crores and an Offer for Sale (OFS) of 1100 crores.

In the OFS, South Lake Investments plans to sell shares worth 800 crores, while founders Aman Gupta and Sameer Mehta intend to sell shares totaling 300 crores (150 crores each). Currently, both founders hold a 28.26 percent stake in the company.

Top 5 Upcoming IPO 2023 : Boat, Oyo, Snapdeal, Emcure Pharmaceuticals andMobikwik

Boat has secured a dominant position in high-growth consumer categories like audio and wearables. Notably, in 2021, 96.01 percent of the company’s total revenue was generated from the audio segment, with the remaining 3.99 percent from other categories. The contribution of the vehicle wearables segment has dwindled from 14.05 percent in 2019 to nearly nonexistent in 2021. A substantial portion of the company’s sales is facilitated through online marketplaces, accounting for 85.84 percent of total sales in 2021, including e-commerce platforms and Boat’s official website.

Financially, the company has demonstrated a consistent upward trajectory. Revenue from operations more than doubled from 609 crores in 2020 to 1313.7 crores in 2021. Interestingly, the company’s revenue for the six-month period from April to September 2021 was 1547 crores. Net profit is also experiencing rapid growth, with a recorded net profit of 118.3 crores from April to September 2021. The company’s EBITDA margin during the same period stood at 11.08 percent, a notable increase from 6.26 percent in 2019.

However, the company acknowledges certain risks, including heavy reliance on online marketplaces, external contracts, manufacturers, and third-party suppliers. Additionally, potential geopolitical tensions between India and China pose a risk to the company’s business. The funds raised through the IPO will be utilized to retire existing debt. This offers a brief overview of the upcoming Boat IPO.

MUST READ : Cello World IPO 2023 : Unlocking the Future of Innovation

OYO IPO

OYO Rooms, founded by Ritesh Agarwal in 2012, started as a platform for short-term hostel bookings. Within a year, Agarwal secured a rare fellowship, mentored by billionaire Peter Thiel. A decade later, he became India’s second-youngest billionaire.

OYO has expanded globally, offering bookings for various accommodations beyond hostels. It’s the third most popular mobile travel app worldwide.

OYO’s business model involves connecting hotels and property owners with customers. The 157,000 listings on its platform, called “storefronts,” aren’t owned by OYO, reducing its expenses.

OYO provides additional services to storefronts using apps like Co-OYO and OYO OS. These apps use AI to help with pricing, performance monitoring, payments, and property photography.

Top 5 Upcoming IPO 2023 : Boat, Oyo, Snapdeal, Emcure Pharmaceuticals andMobikwik

OYO earns by charging hotels and properties 20-35% of the booking value for these services. If a company only wants to be listed, OYO charges a fixed fee. This approach has made OYO successful in the global travel app scene.

Oyo Rooms, founded by Ritesh Agarwal in 2012, has prioritized marketing and branding over the years. Known for its affordability and availability, 70% of bookings happen on the same day. The loyalty program, Oyo Wizards, is India’s second-largest, with 9.2 million members. A whopping 71% of bookings occur through Oyo Wizards, showcasing strong customer loyalty.

Oyo operates in an industry where short-duration bookings contribute significantly, expected to grow to $1.9 trillion by 2030. The industry grows at 6.6% annually due to increased disposable income, social media influence, and improved flight accessibility. Oyo benefits from the unorganized sector, with 88% of hotels and 100% of homes not listed, presenting substantial growth opportunities.

However, Oyo faces stiff competition from players like MakeMyTrip, Trivago, Treebo, Lemontree, and even IRCTC. Financially, in the pre-COVID era (FY 2020), Oyo generated 1300 crores in revenue with a 10% gross profit margin. Despite a 70% revenue drop during COVID, cost rationalization efforts reduced losses by 70%.

Strengths of Oyo include its technology platform creating a network effect, additional services, a strong brand, and a successful loyalty program. The asset-light business model with partial ownership of only 8 facilities allows it to benefit from the travel boom without significant financial burden.

However, Oyo faces challenges. It is not yet profitable, and SoftBank, holding a 46.6% stake, raises potential regulatory issues. Operating in the subjective hospitality industry makes customer satisfaction challenging, impacting branding.

The IPO details include a fresh issue of 7000 crores and an offer for sale of 1450 crores. The funds will be used for prepayment, repayment of loans, storefront base expansion, technology platform enhancement, and general corporate purposes.

In conclusion, while awaiting details like the IPO opening date, lot size, and price band, Oyo’s journey reflects strengths and challenges, showcasing its position in the competitive hospitality industry.

MUST READ : ESAF Small Finance Bank : ESAF Bank, Best Time To Invest 2023

 Snapdeal IPO

Snapdeal Ltd has submitted an IPO filing for approximately Rs.1,250 crore. The IPO is composed of a fresh issue valued at Rs.1,250 crore and an offer for sale involving up to 30,769,600 equity shares. Soft Bank intends to divest up to 30.77 million equity shares in the offer for sale. Additionally, Snapdeal is exploring a pre-IPO placement of Rs.250 crore, which will be deducted from the fresh issue.

The book running lead managers overseeing the IPO include Axis Capital Ltd, BofA Securities India Ltd, CLSA India Pvt Ltd, and JM Financial Ltd.

The primary goal of the issue is to allocate Rs.900 crore of the net proceeds towards supporting organic growth initiatives. The remaining funds will be designated for general corporate needs and initiatives.

Top 5 Upcoming IPO 2023 : Boat, Oyo, Snapdeal, Emcure Pharmaceuticals andMobikwik

 About Snapdeal

Snapdeal is a company that started in 2007 and used to compete with big names like Amazon and Flipkart. In 2020, it became the biggest e-commerce platform in India in terms of revenue. By 2021, it was among the top four online shopping apps in the country. It began as a coupon booklet business, switched to online deals in 2010, and fully embraced e-commerce in 2012. Snapdeal sells a bunch of things like clothes, home stuff, and beauty products.

As of August 31, 2021, Snapdeal has 40.15 million active monthly users and has engaged with 50.37 million customers since 2019. A big chunk, 77.01%, of their business comes from people who buy again, and they have a really good 4.5 rating on the Google Play Store. They have 635 employees as of September 30, 2021, and they are trying to reach more people in smaller cities in India.

Snapdeal makes money by charging fees to sellers for marketing, shipping, and collecting payments. In 2021, Snapdeal started letting people pay cash when they get their delivery. They also have a part of the company called Unicommerce eSolutions Pvt Ltd that helps other brands with their online businesses.

Snapdeal’s new thing called “Power Brands” is all about getting suppliers who sell good stuff at good prices. Since they started, they’ve got 13 “Power Brands,” showing they really care about giving customers good deals.

Financial Overview of Snapdeal Ltd

Particulars Q2 Ended 30 September, 2021 (In Rs cr) FY21 (In Rs cr) FY20 (In Rs cr) FY19 (In Rs cr)
Total Income 252.84 510.27 916.66 925.32
PAT -177 -125.44 -273.54 -187
EPS (In Rs) -4.49 -3.18 -6.94 -7.23
Particulars Q2 Ended 30 September, 2021 (In Rs cr) FY21 (In Rs cr) FY20 (In Rs cr) FY19 (In Rs cr)
Total Assets 683.63 795.35 925.30 1,359.7
Total Borrowings 13.6
Equity Share Capital 39.44 39.44 39.44 39.44
Particulars Q2 Ended 30 September, 2021 (In Rs cr) FY21 (In Rs cr) FY20 (In Rs cr) FY19 (In Rs cr)
Net cash flow from operating activities -110.14 -91.5 -371.84 -34.75
Net cash flow from/used in investing activities 159 140.75 362.9 -0.12
Net cash used in financing activities -1.98 -4.12 -2.92 -33
Particulars Q2 Ended 30 September, 2021 (In Rs cr) FY21 (In Rs cr) FY20 (In Rs cr) FY19 (In Rs cr)
NMV 668.12 912.64 1,760.99 2,127.44
Delivered units (cr) 1.5 1.9 3.5 3.4
Revenue 238.6 471.7 846.4 839.43
Contribution margin 105.6 276.2 473.84 479.85
EBITDA -170.45 -99.87 -320 -244.4

MobiKwik IPO

The IPO is set at Rs. 1,900 crore, with Rs. 1,500 crore as a fresh issue and Rs. 400 crore as an Offer for Sale (OFS). Managing the IPO are IIFL Securities, Credit Suisse Securities, BNP Paribas, ICICI Securities, and Jefferies India Pvt Ltd. The company’s promoters are Bipin Preet Singh, Upasana Rupkrishan Taku, Koshur Family Trust, and Narinder Singh Family Trust.

Top 5 Upcoming IPO 2023 : Boat, Oyo, Snapdeal, Emcure Pharmaceuticals andMobikwik

The objectives of the issue are:

To secure funds for both organic and inorganic growth.
For general corporate purposes.

MobiKwik Financial Status

Particulars FY21 (Rs cr) FY20 (Rs cr) FY19 (Rs cr)
Revenue 288.57 355.67 148.47
PAT -111.3 -99.92 -147.97
EPS (Rs) -22.18 -20.45 -31.01
Particulars FY21 (Rs cr) FY20 (Rs cr) FY19 (Rs cr)
Total Assets 423.14 337.94 335.08
Total Borrowings 60.6 76.47 86.43
Equity Share Capital 1 1 1

Emcure Pharmaceutical IPO

Emcure Pharmaceuticals is a well-established pharmaceutical company based in India. Known for its commitment to providing affordable and high-quality healthcare solutions, Emcure has become a significant player in the global pharmaceutical industry. Here are key aspects about Emcure Pharmaceuticals:

Top 5 Upcoming IPO 2023 : Boat, Oyo, Snapdeal, Emcure Pharmaceuticals andMobikwik

Founding and Establishment: Emcure Pharmaceuticals was founded in 1981 by Satish Mehta and his family. The company has since grown steadily and has become a prominent name in the pharmaceutical sector.

Product Portfolio: Emcure has a diverse portfolio of pharmaceutical products that span various therapeutic areas, including oncology, anti-infectives, cardiovascular, and central nervous system drugs. The company focuses on both generic and branded formulations.

Research and Development: Emcure emphasizes research and development to bring innovative and cost-effective healthcare solutions to the market. The company invests in cutting-edge technologies and collaborations to enhance its product pipeline.

Global Presence: While headquartered in Pune, India, Emcure has expanded its presence globally. The company exports its products to numerous countries and has subsidiaries and alliances with pharmaceutical companies worldwide.

Quality Standards: Emcure Pharmaceuticals adheres to stringent quality standards in manufacturing and has received various certifications, including approvals from regulatory authorities such as the U.S.

Social Responsibility: In addition to its business activities, Emcure is involved in various social responsibility initiatives. The company demonstrates a commitment to healthcare access and community welfare through its corporate social responsibility (CSR) programs.

Strategic Partnerships: Emcure has engaged in strategic partnerships and collaborations with other pharmaceutical companies, research institutions, and healthcare organizations to strengthen its position in the industry and foster innovation.

MUST READ : Dilip Buildcon Stock Price Predictions 2024, 2025, 2030, 2040, and 2050 : Best Time To Invest

Karnika Industries Limited Stock Price Prediction 2024,2025,2030,2040 and 2050

KPI Green Energy Share price Target 2024, 2025, 2030, 2040, and 2050

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top